dual GyrB/ParE inhibitors (Taisho Pharmaceutical)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namedual GyrB/ParE inhibitors (Taisho Pharmaceutical)
Drug Alias Namedual DNA gyrase/topoisomerase IV inhibitors (Taisho Pharmaceutical)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTopoisomerase IV inhibitorsBacterial DNA gyrase inhibitors
TargetsTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsGonorrhea
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTaisho Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTaisho Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsGonorrhea

Other Information

ATC CodeN/A
Related LinksN/A